# Mitsui Sumitomo Insurance Company

> Mitsui Sumitomo Insurance Company is a VC fund backing Financial Services. See 25 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Tokyo, Japan
- Total investments: 25
- Last investment: May 2026
- Lead investor: 28%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/mitsui-sumitomo-insurance-co-ltd-new-zealand-
- Website: http://www.ms-ins.com
- Facebook: https://www.facebook.com/mitsuisumitomo.ins

Mitsui Sumitomo Insurance Company is a VC fund in Tokyo focused on Financial Services and FinTech. Mitsui Sumitomo Insurance Company, Limited ("MSI") was formed in October 2001 through a merger between the former Mitsui Marine & Fire Insurance Co., Ltd.("Mitsui Marine") and the former The Sumitomo Marine & Fire Insurance Co., Ltd. ("Sumitomo Marine").

## Contacts

5 contacts available for Mitsui Sumitomo Insurance Company. Shizune tracks 5 team members at Mitsui Sumitomo Insurance Company. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/mitsui-sumitomo-insurance-company?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Financial Services | 5 | 20% |
| FinTech | 3 | 12% |
| Finance | 3 | 12% |
| InsurTech | 3 | 12% |
| Insurance | 3 | 12% |

65 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 24% |
| Series B | 4 | 16% |
| Venture - Series Unknown | 3 | 12% |
| Seed | 2 | 8% |
| Series C | 2 | 8% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 13 | 52% |
| United States | 7 | 28% |
| China | 1 | 4% |
| Israel | 1 | 4% |
| Germany | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ando Masaaki | Investment Development Principal and Manager | 6 | https://shizune.co/investors/profile/ando-masaaki-3fe4 |
| Junichi Ui | Director, Vice President Executive Officer | 0 | https://shizune.co/investors/profile/junichi-ui |
| Shinichiro Funabiki | Director, Vice President and Executive Officer | 1 | https://shizune.co/investors/profile/shinichiro-funabiki |
| Susumu Fujimoto | Vice President Executive Officer | 0 | https://shizune.co/investors/profile/susumu-fujimoto |
| Toshiaki Egashira | President & CEO | 0 | https://shizune.co/investors/profile/toshiaki-egashira |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Barings | Barings is a $299+ billion* global financial services firm dedicated to meeting the evolving investment and capital needs of their clients. They build lasting partnerships that leverage their distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. |  | Post-IPO Secondary | May 14, 2026 |  |
| Onestruction | Onestruction is an IT firm that offers construction solution development, 3D model and document creation, and operational support services. | $3M | Venture - Series Unknown | Apr 15, 2026 |  |
| QPS Holdings | QPS Holdings is pioneering the future with world-class satellite data, leveraging advanced space-based technologies and data analytics to deliver high-quality geospatial insights that support industries such as environmental monitoring, urban planning, agriculture, and global communications. | $96.6M | Post-IPO Equity | Mar 06, 2026 |  |
| Rakuten Medical | Rakuten Medical is a biotechnology company developing investigational cancer therapies based on its proprietary Alluminox platform. This platform integrates a drug, a device, and other components to deliver photoimmunotherapy, a treatment that combines a light-activated dye with a targeting agent to selectively destroy cancer cells. Thecompany's lead asset, ASP-1929, is an antibody-dye conjugate currently approved in Japan for treating unresectable locally advanced or recurrent head and neck cancer. Rakuten Medical is conducting global clinical trials to evaluate the safety and efficacy of its therapies in combination with other treatments. The company also offers an Expanded Access Program to provide investigational products to patients with serious or life-threatening diseases who lack other treatment options. Rakuten Medical operates in multiple countries and focuses on developing new cancer treatments based on its Alluminox™ platform. | $111.5M | Series F | Jan 07, 2026 |  |
| W. R. Berkley | W. R. Berkley, an insurance holding company, operates as a commercial lines writer in the United States and internationally. It operates through two segments, Insurance and Reinsurance. The Insurance segment underwrites commercial insurance business, including premises operations, commercial automobile, property, products liability, andprofessional liability lines. It also provides workers’ compensation, property casualty, general liability, professional liability, and excess and umbrella coverage insurance products, as well as coverages for technology, ambulatory surgery centers, chiropractors, and concierge physicians; accident and health insurance and reinsurance products; insurance for commercial risks; pollution liability and coverages to contractors, consultants, and owners; and liquor liability and inland marine coverage for small to medium-sized insureds. Moreover, this segment offers directors and officers, and surety risk products, as well as products for life sciences and travel industries; coverage for excess liability, construction wrap-ups, and completed operations; cyber risk solutions; casualty, group life, and crime-related insurance products; personal lines insurance solutions, including home, condo/co-op, and collectibles; automobile, law enforcement, public officials and educator's legal, and employment practices liability, as well as incidental medical insurance products; and at-risk and alternative risk insurance program management services. The Reinsurance segment provides other insurance companies and self-insureds with assistance in managing their net risk through reinsurance on a portfolio basis through treaty reinsurance or on an individual basis through facultative reinsurance. William R. Berkley founded W. R. Berkley in 1967. It has its headquarters in Greenwich in Connecticut. |  | Post-IPO Equity | Dec 05, 2025 |  |
| CoreTissue BioEngineering | CoreTissue BioEngineering is a development of an artificial ligament for reconstruction of the anterior cruciate ligament in Japan. | $3.9M | Series A | Nov 10, 2025 |  |
| T2 | T2 Co offers services like automatic driving of huge trucks to provide a trunk transportation service. | $33.8M | Series B | Aug 18, 2025 |  |
| Coalition | Coalition is an active insurance company that combines comprehensive insurance and proactive cybersecurity tools to help businesses manage and mitigate cyber risk. Backed by leading global insurers Allianz, Swiss Re Corporate Solutions, Arch Insurance North America, Lloyd’s of London, and Ascot Group, Coalition offers its insurance products in theUS and Canada and its security products to organizations globally. Coalition’s Active Risk Platform provides automated security alerts, threat intelligence, expert guidance, and cybersecurity tools to help businesses remain resilient in the face of cyber attacks. Headquartered in San Francisco, Coalition is a distributed company with a global workforce that collaborates both digitally and in-office hubs across the globe. | $30M | Corporate Round | Mar 03, 2025 |  |
| DigitalArchi | DigitalArchi is a manufacturing company that offers interior parts, fixtures, concrete formwork for construction, recycle and sells plastic. | $2.3M | Seed | Jan 16, 2025 |  |
| Smart Bank | Smart Bank is a softawre firm that has developed an application for money spending management. | $18.9M | Series B | Nov 12, 2024 |  |

10 of 25 investments shown.

## Co-investors
- [DBJ Capital](https://shizune.co/investors/profile/dbj-capital) — VC Fund, 2 deals together
- [Global Brain Corporation](https://shizune.co/investors/profile/global-brain-corporation) — VC Fund, 2 deals together
- [KDDI](https://shizune.co/investors/profile/kddi) — VC Fund, 2 deals together
- [MITSUI-SOKO HOLDINGS](https://shizune.co/investors/profile/mitsui-soko-holdings) — VC Fund, 2 deals together
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund, 2 deals together
- [MS&AD Insurance Group Holdings](https://shizune.co/investors/profile/ms-ad-insurance-group-holdings) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Courtside Ventures](https://shizune.co/investors/profile/courtside-ventures) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Sports VC Funds in Japan](https://shizune.co/investors/sports-vc-funds-japan)

## FAQ

### What does Mitsui Sumitomo Insurance Company invest in?

Mitsui Sumitomo Insurance Company invests primarily in Financial Services, FinTech and Finance startups, most often at Series A and Series B stage. Most of the 25 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Mitsui Sumitomo Insurance Company?

Public channels for Mitsui Sumitomo Insurance Company include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Mitsui Sumitomo Insurance Company?

The team at Mitsui Sumitomo Insurance Company includes Ando Masaaki (Investment Development Principal and Manager), Junichi Ui (Director, Vice President Executive Officer) and Shinichiro Funabiki (Director, Vice President and Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co